Coya Therapeutics, Inc. · NASDAQ:COYA
The Vanguard Group's stake in Coya Therapeutics, Inc. fell to 4.29% (Schedule 13G/A)
Event Dec 31, 2025 · Filed Jan 30, 2026
The Vanguard Group's stake in Coya Therapeutics, Inc. fell to 4.29%, 899,140 shares, as a passive investor on Dec 31, 2025. Filed Jan 30, 2026 (Schedule 13G/A).
- Stake
- 4.29%
- Shares
- 899,140
- Intent
- Passive
- What changed
- Fell below 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| The Vanguard Group | 4.29% | 899,140 |
Source
Related
- Coya Therapeutics, Inc.
- The Vanguard Group
- Coya Therapeutics, Inc. shareholders
- Schedule 13G/A · Orin Hirschman · Jul 27, 2026
- Schedule 13G · Dr. Reddy's Laboratories, Inc. · Mar 12, 2026
- Schedule 13G/A · Orin Hirschman · Jan 28, 2026
- Schedule 13G/A · DME Capital Management, LP · Feb 14, 2025
- Schedule 13G/A · Orin Hirschman · Feb 10, 2025